Danger’s of DePuy Pinnacle System A New Concern for Patients
DePuy Orthopaedics, a subsidiary of healthcare product maker Johnson & Johnson, has been embroiled in legal controversy regarding their past products for severe defective issues, according to medical industry analysts. Claims from patients and testimonies from medical experts have formed the core of the legal problems alleging that DePuy failed to properly test and inform the public, along with regulators, about the dangers associated with their hip implants.
Hip replacement surgery is one of the procedures claimed by companies, such as DePuy Orthopaedics, as being an important part in maintaining healthy function for elderly patients. As we grow older our skeleton grows frailer as our bones get weaker, according to the company’s claims. The company’s promoters say that, by providing a line of hip replacement implants, they can guarantee a life free of worry from the infirmity of growing old. DePuy recommends their implants for patients over the age of 60 or those suffering from osteoporotic fractures, but their marketing campaigns have influenced younger clients to also have them with a guarantee from the company of living a fuller healthier lifestyle in preparation for a time when they would eventual need it.
It seems that promise has, sadly, not been delivered. In the last five years DePuy has struggled to minimize its business losses while trying to battle legal claims that their hip implants were defective and the cause of serious injuries. The most prominent example of the problems DePuy faced was the recall of their XL ASR hip resurfacing and replacement implants in late 2010, which were found to be defective and the cause of severe complications such as metal ion toxicity, pain, infection, wounds and fractures related to the implant being dislocated, loosened and misaligned.
DePuy has recently come out with a new implant called the Pinnacle system which, after extensive testing, regulators in the UK and Japan did not approve of. Medical experts from both countries have decried the implant device as being prone to defects potentially affecting as much as 80% of patients who’ve received them to require life-long monitoring due to being at great risk of developing complications similar to the ones documented with the ASR system.
Adding to the controversy already heaped on DePuy, regulators clam that Depuy’s executives had prior knowledge of the Pinnacle implant’s defective nature but chose to go ahead and sell it anyway which further damages the fragile credibility of the company as a trustworthy company.
There have been a great number of legal complaints filed against the company with some still pending from the recall of the ASR system with more predicted to come from the continued sale of the Pinnacle system.